Table 3.

Top 20 differentially methylated CpG sites resulting from the comparison between BPD+T patients (N = 49) and BPD-T patients (N = 47).

CpG site	P value	Q value	B	Chr.	Chr. Position	Gene	Gene region
cg01652665	1.25E−06	5.30E−01	3.71	14	36987722	NKX2-1	Body
cg24786705	4.11E−06	8.73E−01	2.55	5	34500318		IGR^a
cg10888111	6.44E−06	9.11E−01	2.12	2	1637068	PXDN	3′UTR^a
cg15948871	1.01E−05	9.46E−01	1.68	6	31139620	POU5F1	TSS1500^a
cg05762616	1.41E−05	9.46E−01	1.35	10	133787150	BNIP3	Body
cg13911052	1.47E−05	9.46E−01	1.32	2	176978909		IGR
cg24846397	1.56E−05	9.46E−01	1.26	10	133787150	CASP7	TSS1500
cg24915915	1.99E−05	9.54E−01	1.02	2	231799064		IGR
cg04511534	2.02E−05	9.54E−01	1.01	17	4463371	GGT6	Body^a
cg16465769	2.75E−05	0.999985	0.71	6	43266151	SLC22A7	1stExon^a
cg01862363	3.21E−05	0.999985	0.56	17	8928028	NTN1	Body
cg12575928	3.37E−05	0.999985	0.51	11	22687660	GAS2	TSS1500
cg02481697	3.68E−05	0.999985	0.43	17	8928012	NTN1	Body
cg20989454	3.82E−05	0.999985	0.39	11	613478	IRF7	Body
cg24319547	3.90E−05	0.999985	0.37	6	33168857	SLC39A7	1stExon
cg17207064	4.08E−05	0.999985	0.33	2	17982866		IGR
cg00914033	4.58E−05	0.999985	0.22	10	81664698		IGR
cg27190024	4.82E−05	0.999985	0.17	7	94034528	COL1A2	Body
cg10969178	5.55E−05	0.999985	0.03	6	31838402	SLC44A4	Body
cg06759559	6.37E−05	0.999985	−0.10	1	7028331	CAMTA1	Body

Q value indicates FDR corrected p values. B indicates log-odds that the gene is differentially expressed.

^aCpGs in two studies: BPD+T vs. BPD-T & CTL and BPD+T vs. BPD-T.